CRM
60
-7
EFX
30
-8
CSX
57
-4
DGX
48
11
AAP
35
-9
CA
22
-3
DAL
84
-3
MUR
44
-3
A
37
-2
SCHW
62
-2
PYPL
52
-2
EXR
57
2
HST
39
-3
SYF
86
-6
C
62
4
CMG
66
-4
XOM
42
-6
AMGN
42
-4
VRTX
47
-6
AAPL
40
-6
CRM
60
-7
EFX
30
-8
CSX
57
-4
DGX
48
11
AAP
35
-9
CA
22
-3
DAL
84
-3
MUR
44
-3
A
37
-2
SCHW
62
-2
PYPL
52
-2
EXR
57
2
HST
39
-3
SYF
86
-6
C
62
4
CMG
66
-4
XOM
42
-6
AMGN
42
-4
VRTX
47
-6
AAPL
40
-6
Financhill
Back

Goldman Sachs Access Hi Yld Corp Bd ETF Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
30

GHYB
Goldman Sachs Access Hi Yld Corp Bd ETF

Last Price:
44.86
Seasonality Move:
0.44%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Sell
30
Goldman Sachs Access Hi Yld Corp Bd ETF (GHYB) is a Sell

Is Goldman Sachs Access Hi Yld Corp Bd ETF a Buy, Sell or Hold?

  • The current Goldman Sachs Access Hi Yld Corp Bd ETF [GHYB] share price is $44.94. The Score for GHYB is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • GHYB is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

GHYB Stock Price Chart

What is Goldman Sachs Access Hi Yld Corp Bd ETF's stock price today?

  • The Goldman Sachs Access Hi Yld Corp Bd ETF share price today is $44.94
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GHYB is experiencing buying pressure, which is a positive indicator for future bullish movement.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

GHYB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.03 Sell
Relative Strength Index (14 RSI): 46.07 Sell
Chaikin Money Flow: 11832 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (44.86 - 45.18) Sell
Bollinger Bands (100): (44.42 - 45.3) Buy

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

GHYB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 45.06 Sell
20-day SMA: 44.98 Sell
50-day SMA: 45.17 Sell
200-day SMA: 44.34 Buy
8-day EMA: 45 Sell
20-day EMA: 45.02 Sell
50-day EMA: 45.02 Sell
200-day EMA: 44.42 Buy

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

Goldman Sachs Access Hi Yld Corp Bd ETF Earnings Growth & GHYB Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

Goldman Sachs Access Hi Yld Corp Bd ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):